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Can serum cytokines predict hepatic cytokine expression in liver cirrhosis?Cytokines are involved in liver injury and cirrhosis. However,
studies to explore whether systemic and hepatic cytokine levels
can help in predicting cirrhosis progression are limited. Common
bile duct ligation (BDL) is a well-established animal model used
to induce cholestatic liver injury with inflammation, fibrosis, and
cirrhosis.1 The study by Hsieh et al study is characterized by
a systemic approach to evaluate the overall picture of hepatic and
circulating cytokines, including IFN-g, TNF-a, IL-10 and
TGF-b, during cirrhosis development.2 Their study shows that
cirrhosis development is associated with progressively enhanced
hepatic pro- and anti-inflammatory cytokine expression in BDL
rats. However, corresponding serum concentrations were not
completely in accordance with hepatic cytokine expression in
BDL rats.2 Hsieh et al conclude that circulating cytokine
concentrations may not totally reflect their hepatic expression
levels during the development of cirrhosis.2
The roles of cytokines, which may be responsible for initi-
ation and progression of hepatic injury, fibrosis and cirrhosis,
but can also participate in liver regeneration, are complicated in
hepatic damage.3 Elevated circulating TNF-a has been
observed in patients with alcoholic liver disease, especially
those who are malnourished, and has been correlated with
survival.4 Increased circulating TNF-a has been reported in
patients with viral hepatitis.5 Hepatic expression of TNF-a is
upregulated in autoimmune liver disease, alcoholic hepatitis and
cirrhosis.6 Hsieh et al observed that hepatic TNF-a expression
rather than serumTNF-awasmarkedly elevated inBDL rats.2 A
previous study suggested that TNF-a plays a central role in
hepatic regeneration following both toxic and partial hepatec-
tomy. Exogenous TNF-a stimulates hepatic DNA synthesis in
rodents and accelerates recovery of liver weight following
partial hepatectomy.7 Hepatic regeneration following chemi-
cally induced hepatotoxicity is also impaired in TNF type 1
receptor knockout mice and following anti-TNF-a antibody
administration.7 In fact, Kupffer cell blockade augments hepatic
regeneration following partial hepatectomy secondary to
impaired IL-10 release from these cells, which allowed sus-
tained unopposed TNF-a production from endothelial cells.8
Hsieh et al observed that the trends for serum TNF-a changes
were not consistent with those for hepatic TNF-a expression
levels, which suggests that measurement of serum TNF-a
cannot reflect hepatic TNF-a expression.2
Previous studies revealed that hepatic IFN-g mRNA corre-
lated with the degree of liver damage.9 Natgonat et al reported1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.09.002that hepatic IFN-gmRNA expression was higher in liver biopsy
specimens from patients with primary biliary cirrhosis than in
normal control individuals.10 The study by Hsieh et al is the
first to directly measure hepatic IFN-g expression by immu-
nohistochemial staining.2 Consistent with a previous study,
Hsieh et al find that serum concentrations of IFN-g were not in
parallel with hepatic expression levels during progression of
hepatic inflammation and necrosis.2,11 It has been reported that
hepatic levels of TGF-b were positively correlated with the
degree of liver fibrosis in rats with biliary cirrhosis.12 Hsieh
et al show that serum TGF-b concentrations are positively
correlated with hepatic TGF-b expression in BDL rats. In
patients with primary biliary cirrhosis, high serum TNF-a is
accompanied by severe liver fibrosis, as graded by liver biopsy.
Meanwhile, regression of hepatic fibrosis on ursodeoxycholic
acid therapy is associated with decreases in serum TNF-a in
patients with primary biliary cirrhosis.13 Taken together, these
interesting results indicate that serum TNF-a might be
a candidate marker for prediction of the degree of liver fibrosis.
The endogenous anti-inflammatory cytokine IL-10 has
potent anti-inflammatory and anti-fibrotic properties. In
carbon tetrachloride-induced liver injury, IL-10 inhibits acute
inflammation and limits the proliferative response of hepato-
cytes and delays the development of fibrosis during liver
repair.14 Hsieh et al observed that higher hepatic IL-10
expression was accompanied by lower serum levels of IL-10
in BDL rats than in sham rats. The mechanism for relatively
low serum IL-10 might involve rapid clearance of IL-10 by
BDL-induced cirrhotic liver due to upregulation of the hepatic
IL-10 receptor.15
In conclusion, the study results reported by Hsieh et al are
valuable in furthering our understanding of progressive
enhancement of both pro- and anti-inflammatory cytokine
expression in liver during the development of cirrhosis in BDL
rats.2 Nonetheless, only some of the changes in serum cyto-
kine concentrations are consistent with the corresponding
hepatic expression, which implies that a complex interplay of
cytokine production, utilization and metabolism occurs in liver
injury.
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